Free US stock screening tools combined with expert analysis to help you identify undervalued companies with strong growth potential. We use sophisticated algorithms and human expertise to surface opportunities that might otherwise go unnoticed.
As of April 6, 2026, MiniMed Group Inc. (MMED) trades at a current price of $13.53, marking a 3.43% decline in recent trading activity. No recent earnings data is available for the medtech firm at the time of writing, so this analysis focuses on prevailing market context, technical price levels, and potential short-term scenarios for the stock. Key near-term levels to track include a support floor at $12.85 and a resistance ceiling at $14.21, both of which have been tested repeatedly in recent t
Is MiniMed Group (MMED) Stock a Good Buy in 2026 | Price at $13.53, Down 3.43% - Weak Sell Rating
MMED - Stock Analysis
3139 Comments
534 Likes
1
Samhith
Power User
2 hours ago
This feels like a clue to something bigger.
👍 168
Reply
2
Marlicia
Legendary User
5 hours ago
Oh no, should’ve seen this sooner. 😩
👍 29
Reply
3
Con
Community Member
1 day ago
I reacted before thinking, no regrets.
👍 84
Reply
4
Otilla
Community Member
1 day ago
Anyone else just connecting the dots?
👍 247
Reply
5
Rhyelle
Engaged Reader
2 days ago
Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
👍 28
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.